(Investorideas.com Newswire) A popular platform for great investment ideas, including biotech and medical tech stocks, issues a news and trading alert for Skinai ImmunoTherapeutics Ltd.Nasdaq: SCNI).
Skinai ImmunoTherapeutics Ltd (Nasdaq: SCNI) is on the Nasdaq top gainers list today, currently trading at +0.8867 +0.4307 (+94.45%) on volume of 162 million shares as of this report.
It seems that retailers are moving the stock after the news and promotion news.
Skinai ImmunoTherapeutics today announced that it has entered into a securities purchase agreement with an institutional life sciences investor, as well as new and existing institutional and accredited investors for the purchase and sale of 5,208,333 American Depositary Shares (ADS), each representing 4,000 ordinary shares, at a purchase price of $0.48 per ADS, as well as 5,208,333 ADSs. Also Series A Warrants for the purchase of up to. Series B warrants to purchase up to 5,208,333 ADSs at an exercise price of $0.48 per ADS, immediately exercisable with a term of two years, and Series B warrants to purchase up to 5,208,333 ADSs at an exercise price of $0.55 per ADS, immediately exercisable with a term of five years.
Skinai ImmunoTherapeutics Ltd (Nasdaq: SCNI) is a biopharmaceutical company focused on the development of innovative immunology treatments. The company is pursuing a pipeline of therapeutic candidates licensed from the Max Planck Society and Pincel S.r.l.
Skinai also owns Skinai Biopharma Services Ltd., a contract development and manufacturing organization (CDMO) that provides development and manufacturing services to biotechnology and pharmaceutical companies. www.scinai.com
Research biotech stocks on Investorideas.com
https://www.investorideas.com/BIS/stock_list.asp
Join the Investigates Telegram discussion about biotech stocks
https://www.investorideas.com/membership/
About Investorideas.com – where you find the best investing ideas
Investorideas.com is the go-to platform for great investment ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts like Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and AI Eye. We also create free investor stock directories for mining, crypto, renewable energy, gaming, biotech, tech, sports and other sectors. Public companies in the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Paid content is always disclosed.
Disclaimer/Disclosure Our site does not constitute recommendations for the purchase or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investments involve risk and possible loss. The site currently offers compensation for news publishing and distribution, social media and marketing, content creation, and more. Disclosure is posted for each compensated news release, if necessary the published/produced content is published, but otherwise was not compensated for the news and was published for the sole interest of our readers and followers. Contact each company’s management and IR directly regarding specific questions. More Disclaimer Information: More Disclaimer and Disclosure Information https://www.investorideas.com/About/Disclaimer.asp Global investors must follow the regulations of each country. Please read the Privacy Policy of Investorideas.com: https://www.investorideas.com/About/Private_Policy.asp
Learn more about our news, PR and social media, podcast services for AI stocks at Investorideas.com
https://www.investorideas.com/Investors/Services.asp
Learn more about digital advertising and guest posting for AI
https://www.investorideas.com/Advertise/
Follow us on X @investorideas @stocknewsbites
Follow us on Facebook
https://www.facebook.com/Investorideas
Follow us on You Tube
https://www.youtube.com/c/Investorideas
Sign up for free stock news alerts at Investorideas.com
https://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/Disclosure: Investorideas.com is a digital publisher of news, articles and equity research sourced from third parties and also creates original content including videos, interviews and articles. Original content created by Investidea is protected by copyright laws in addition to syndication rights. Our site does not make recommendations for the purchase or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investments involve risk and possible loss of investment. The site currently offers compensation for news publishing and distribution, social media and marketing, content creation, and more. Contact each company directly regarding content and press release questions. More Disclaimer information: http://www.investorideas.com/About/Disclaimer.asp. This article is a third party guest post published content and not the content of Investorideas.com. Learn more about posting your articles at http://www.investorideas.com/Advertise/
Please read the Privacy Policy of Investorideas.com: https://www.investorideas.com/About/Private_Policy.asp
